tirzepatide being discontinued Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide vs Semaglutide Trial Results

Semaglutide, like other diabetic drugs, causes mild weight loss and has been demonstrated to be cardioprotective (meaning it reduces the risk of heart attacks) and nephroprotective (meaning it safeguards kidney function)

Oncol Lett 2015

Understanding Baylor Scott & White Health Plan Understanding the Baylor Scott & White Health Plan is the first step toward accessing a world of comprehensive health coverage

Applesauce contains pectin, a soluble fiber that helps solidify stools

You might be running low on Vitamin B12

We help with your dosing schedule, talk through any side effects, and give tips about lifestyle changes that work well